Preleukemia in long-term plasmacytoma-regressor mice.

Abstract excerpt

Our previous results have indicated that mice whose plasmacytoma regressed following curative melphalan chemotherapy manifested various persistent immunohematological abnormalities including immunosuppression, myeloproliferation, as well as excessive production of and response to growth factors. Mice not bearing plasmacytoma treated with an identical dose of melphalan chemotherapy did not exhibit such...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Plasmacytoma
• Share to Spleen
• Share to Time Factors